These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19917141)

  • 1. Expression of complement system components during aging and amyloid deposition in APP transgenic mice.
    Reichwald J; Danner S; Wiederhold KH; Staufenbiel M
    J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
    Zhou J; Fonseca MI; Pisalyaput K; Tenner AJ
    J Neurochem; 2008 Sep; 106(5):2080-92. PubMed ID: 18624920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition.
    Fan R; DeFilippis K; Van Nostrand WE
    J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
    Emmerling MR; Spiegel K; Watson MD
    Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.
    Bulla R; Tripodo C; Rami D; Ling GS; Agostinis C; Guarnotta C; Zorzet S; Durigutto P; Botto M; Tedesco F
    Nat Commun; 2016 Feb; 7():10346. PubMed ID: 26831747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.
    Lüth HJ; Holzer M; Gärtner U; Staufenbiel M; Arendt T
    Brain Res; 2001 Sep; 913(1):57-67. PubMed ID: 11532247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy.
    Wu T; Dejanovic B; Gandham VD; Gogineni A; Edmonds R; Schauer S; Srinivasan K; Huntley MA; Wang Y; Wang TM; Hedehus M; Barck KH; Stark M; Ngu H; Foreman O; Meilandt WJ; Elstrott J; Chang MC; Hansen DV; Carano RAD; Sheng M; Hanson JE
    Cell Rep; 2019 Aug; 28(8):2111-2123.e6. PubMed ID: 31433986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.
    Fonseca MI; Chu SH; Berci AM; Benoit ME; Peters DG; Kimura Y; Tenner AJ
    J Neuroinflammation; 2011 Jan; 8(1):4. PubMed ID: 21235806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.
    Fonseca MI; Zhou J; Botto M; Tenner AJ
    J Neurosci; 2004 Jul; 24(29):6457-65. PubMed ID: 15269255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5.
    Behnsen J; Lessing F; Schindler S; Wartenberg D; Jacobsen ID; Thoen M; Zipfel PF; Brakhage AA
    Infect Immun; 2010 Aug; 78(8):3585-94. PubMed ID: 20498262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.
    Ager RR; Fonseca MI; Chu SH; Sanderson SD; Taylor SM; Woodruff TM; Tenner AJ
    J Neurochem; 2010 Apr; 113(2):389-401. PubMed ID: 20132482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer disease: involvement of the complement system in cell death. Gene expression of C1q and C3 in the frontal cortex of patients with Alzheimer disease and control probands].
    Fischer B; Popa-Wagner A
    Fortschr Med; 1996 May; 114(13):161-3. PubMed ID: 8964559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.
    Shi Q; Chowdhury S; Ma R; Le KX; Hong S; Caldarone BJ; Stevens B; Lemere CA
    Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilymphocytic antibodies and marrow transplantation. XIV. Antibody-induced suppression of graft-versus-host disease in C3-decomplemented mice differentiates two T-cell-depletion pathways.
    Thierfelder S; Mysliwietz J; Hoffmann-Fezer G; Kummer U
    Blood; 1991 May; 77(10):2285-91. PubMed ID: 2029584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.